1. Repository of OAI
Ελληνικά   English  

Browsing by Author Athyros, V. G.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 21 to 40 of 50 < previous   next >
TitleAuthor(s)Issue date???itemlist.???
Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemiaMilionis, H. J.; Kakafika, A. I.; Tsouli, S. G.; Athyros, V. G.; Bairaktari, E. T.; Seferiadis, K. I.; Elisaf, M. S.24-Nov-2015-
Effects of various fibrates on serum alkaline phosphatase activityGanotakis, E.; Tsimihodimos, V.; Bairaktari, E.; Rizos, E.; Athyros, V. G.; Seferiades, C.; Elisaf, M. S.24-Nov-2015-
Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander?Tsouli, S. G.; Liberopoulos, E. N.; Mikhailidis, D. P.; Athyros, V. G.; Elisaf, M. S.24-Nov-2015-
European Panel on Low Density Lipoprotein (LDL) Subclasses: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL SubclassesMikhailidis, D. P.; Elisaf, M.; Rizzo, M.; Berneis, K.; Griffin, B.; Zambon, A.; Athyros, V. G.; de Graaf, J.; Marz, W.; Parhofer, K. G.; Rini, G. B.; Spinas, G. A.; Tomkin, G. H.; Tselepis, A. D.; Wierzbicki, A. S.; Winkler, K.; Florentin, M.; Liberopoulos, E.24-Nov-2015-
Fenofibrate and losartanDaskalopoulou, S. S.; Mikhailidis, D. P.; Athyros, V. G.; Papageorgiou, A. A.; Elisaf, M. S.24-Nov-2015-
Identifying and attaining LDL-C goals: mission accomplished? Next target: new therapeutic options to raise HDL-C levelsAthyros, V. G.; Mikhailidis, D. P.; Kakafika, A. I.; Karagiannis, A.; Hatzitolios, A.; Tziomalos, K.; Ganotakis, E. S.; Liberopoulos, E. N.; Elisaf, M. S.24-Nov-2015-
The impact of serum uric acid on cardiovascular outcomes in the LIFE studyDaskalopoulou, S. S.; Athyros, V. G.; Elisaf, M. S.; Mikhailidis, D.24-Nov-2015-
Inflammatory markers and the metabolic syndromeAthyros, V. G.; Elisaf, M. S.; Mikhailidis, D. P.24-Nov-2015-
Is the risk for cardiovascular disease increased in all phenotypes of the polycystic ovary syndrome?Daskalopoulos, G. N.; Karkanaki, A.; Karagiannis, A.; Mikhailidis, D. P.; Athyros, V. G.24-Nov-2015-
Long-Term Impact of Multifactorial Treatment on New-Onset Diabetes and Related Cardiovascular Events in Metabolic Syndrome: A Post Hoc ATTEMPT AnalysisAthyros, V. G.; Elisaf, M. S.; Alexandrides, T.; Achimastos, A.; Ganotakis, E.; Bilianou, E.; Karagiannis, A.; Liberopoulos, E. N.; Tziomalos, K.; Mikhailidis, D. P.24-Nov-2015-
New-onset diabetes after transplantationLiberopoulos, E. N.; Athyros, V. G.; Elisaf, M. S.; Mikhailidis, D. P.24-Nov-2015-
Non-high density lipoprotein cholesterol and coronary events during long-term statin treatmentAthyros, V. G.; Papageorgiou, A. A.; Symeonidis, A. N.; Elisaf, M. S.24-Nov-2015-
Percutaneous transluminal renal angioplasty in patients with renovascular hypertension: long-term resultsKaragiannis, A.; Douma, S.; Voyiatzis, K.; Petidis, K.; Athyros, V. G.; Vizantiadis, A.; Voujiouklis, N.; Zafiriades, E.; Efremidis, S.; Zamboulis, C.24-Nov-2015-
Prevalence of atherosclerotic vascular disease among subjects with the metabolic syndrome with or without diabetes mellitus: the METS-GREECE Multicentre StudyAthyros, V. G.; Mikhailidis, D. P.; Papageorgiou, A. A.; Didangelos, T. P.; Ganotakis, E. S.; Symeonidis, A. N.; Daskalopoulou, S. S.; Kakafika, A. I.; Elisaf, M. S.24-Nov-2015-
The prevalence of the metabolic syndrome using the National Cholesterol Educational Program and International Diabetes Federation definitionsAthyros, V. G.; Ganotakis, E. S.; Elisaf, M. S.; Mikhailidis, D. P.24-Nov-2015-
Prevalence of vascular disease in metabolic syndrome using three proposed definitionsAthyros, V. G.; Ganotakis, E. S.; Elisaf, M. S.; Liberopoulos, E. N.; Goudevenos, I. A.; Karagiannis, A.24-Nov-2015-
The role of renin-angiotensin system inhibition in the treatment of hypertension in metabolic syndrome: are all the angiotensin receptor blockers equal?Karagiannis, A.; Mikhailidis, D. P.; Athyros, V. G.; Kakafika, A. I.; Tziomalos, K.; Liberopoulos, E. N.; Florentin, M.; Elisaf, M. S.24-Nov-2015-
Safety and impact on cardiovascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT studyAthyros, V. G.; Giouleme, O.; Ganotakis, E. S.; Elisaf, M. S.; Tziomalos, K.; Vassiliadis, T.; Liberopoulos, E. N.; Theocharidou, E.; Karagiannis, A.; Mikhailidis, D. P.24-Nov-2015-
Should atenolol still be recommended as first-line therapy for primary hypertension?Karagiannis, A.; Athyros, V. G.; Papageorgiou, A.; Tziomalos, K.; Elisaf, M. S.24-Nov-2015-
Statin treatment may be beneficial to both the kidneys and the heartAthyros, V. G.; Karagiannis, A.; Liberopoulos, E. N.; Elisaf, M. S.; Mikhailidis, D. P.24-Nov-2015-
Showing results 21 to 40 of 50 < previous   next >